OI
TMO icon

Oakbrook Investments’s Thermo Fisher Scientific TMO Stock Holding History

Oakbrook Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-6,050
Closed -$1.97M – 473
2019
Q4 		$1.97M Sell
6,050
-12,200
-67% -$3.7M 0.4% 38
2019
Q3 		$5.32M Sell
18,250
-1,375
-7% -$394K 0.35% 45
2019
Q2 		$5.76M Buy
19,625
+2,700
+16% +$744K 0.35% 50
2019
Q1 		$4.63M Buy
16,925
+4,700
+38% +$1.17M 0.28% 60
2018
Q4 		$2.74M Buy
12,225
+10,975
+878% +$2.57M 0.19% 90
2018
Q3 		$305K Buy
+1,250
New +$288K 0.02% 543
2018
Q2 		– Sell
-15,785
Closed -$3.26M – 613
2018
Q1 		$3.26M Buy
15,785
+685
+5% +$144K 0.2% 83
2017
Q4 		$2.87M Sell
15,100
-1,125
-7% -$216K 0.18% 88
2017
Q3 		$3.07M Sell
16,225
-10,625
-40% -$1.92M 0.2% 90
2017
Q2 		$4.68M Buy
26,850
+8,575
+47% +$1.44M 0.31% 64
2017
Q1 		$2.81M Sell
18,275
-17,725
-49% -$2.71M 0.18% 100
2016
Q4 		$5.08M Buy
+36,000
New +$5.31M 0.33% 62
2016
Q3 		– Sell
-44,150
Closed -$6.52M – 590
2016
Q2 		$6.52M Buy
+44,150
New +$6.52M 0.36% 64
2016
Q1 		– Sell
-43,475
Closed -$6.17M – 566
2015
Q4 		$6.17M Buy
+43,475
New +$5.8M 0.39% 62
2015
Q3 		– Sell
-48,775
Closed -$6.33M – 568
2015
Q2 		$6.33M Buy
48,775
+500
+1% +$65.2K 0.39% 60
2015
Q1 		$6.49M Buy
48,275
+2,825
+6% +$364K 0.35% 71
2014
Q4 		$5.69M Buy
45,450
+13,675
+43% +$1.66M 0.31% 72
2014
Q3 		$3.87M Sell
31,775
-71,975
-69% -$8.75M 0.21% 120
2014
Q2 		$12.2M Sell
103,750
-15,000
-13% -$1.77M 0.37% 74
2014
Q1 		$14.3M Buy
+118,750
New +$14.1M 0.45% 57
2013
Q3 		– Sell
-151,625
Closed -$12.8M – 654
2013
Q2 		$12.8M Buy
+151,625
New +$12.6M 0.37% 67

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Oakbrook Investments's TMO Position: Q1 2020 in Review

Oakbrook Investments sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 6,050 shares — an estimated $1.97M sold.

Oakbrook Investments first reported a position in TMO in Q2 2013 and held it in 21 quarters. The position peaked at $14.3M in Q1 2014. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

  • Oakbrook Investments reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
  • Oakbrook Investments sold 6,050 Thermo Fisher Scientific shares in Q1 2020, an estimated $1.97M.
  • Oakbrook Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 21 quarters.
  • Oakbrook Investments's Thermo Fisher Scientific position peaked at $14.3M in Q1 2014.
  • 1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.